AYTU

AYTU BIOPHARMA, INC SEC filings

Every EDGAR filing for AYTU BIOPHARMA, INC (AYTU), newest first, with AI summaries and stories.

Ticker: AYTU
CIK: 1385818
Sector: Biotech and pharma
Latest filing: Sep 22

Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16) · usually files the same day as earnings

Watch in the app Get the app

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

NOTABLE10-KAYTU BIOPHARMA, INCAYTUSep 22
Annual report
Company Filing
ROUTINE8-KAYTU BIOPHARMA, INCAYTUSep 22
Current report
Company Filing
ROUTINESCHEDULE 13G/AAYTU BIOPHARMA, INCAYTUAug 14
Ownership stake disclosure by Laurence W Lytton (amended)
Company Filing
Laurence W Lytton, filed by
ROUTINE4AYTU BIOPHARMA, INCAYTUJul 30
8 insider filings
Joshua R. Disbrow, insider filing for AYTU
Show all 8
- 4Insider filing for AYTUJul 30
- 4Insider filing for AYTUJul 30
- 4Insider filing for AYTUJul 30
- 4Insider filing for AYTUJul 30
- 4Insider filing for AYTUJul 30
- 4Insider filing for AYTUJul 30
- 4Insider filing for AYTUJul 30
- 4Insider filing for AYTUJul 30
Joshua R. Disbrow, reporting
ROUTINE8-KAYTU BIOPHARMA, INCAYTUJun 25
Current report
Company Filing
NOTABLE10-QAYTU BIOPHARMA, INCAYTUMay 13
Quarterly report
Company Filing
ROUTINE8-KAYTU BIOPHARMA, INCAYTUMay 13
Current report
Company Filing
ROUTINE8-KAYTU BIOPHARMA, INCAYTUApr 2
Current report
Company Filing
ROUTINESCHEDULE 13G/AAYTU BIOPHARMA, INCAYTUFeb 17
Ownership stake disclosure by Laurence W Lytton (amended)
Company Filing
Laurence W Lytton, filed by
ROUTINESCHEDULE 13G/AAYTU BIOPHARMA, INCAYTUFeb 13
Ownership stake disclosure by AWM Investment Company, Inc. (amended)
Company Filing
AWM Investment Company, Inc., filed by
NOTABLE10-QAYTU BIOPHARMA, INCAYTUFeb 3
Quarterly report
Company Filing
ROUTINE8-KAYTU BIOPHARMA, INCAYTUFeb 3
Current report
Company Filing
ROUTINE8-KAYTU BIOPHARMA, INCAYTUJan 20
Current report
Company Filing
ROUTINE8-KAYTU BIOPHARMA, INCAYTUDec 10, 2025
Current report
Company Filing
ROUTINESCHEDULE 13G/AAYTU BIOPHARMA, INCAYTUNov 14, 2025
Ownership stake disclosure by Laurence W Lytton (amended)
Company Filing
Laurence W Lytton, filed by
NOTABLE10-QAYTU BIOPHARMA, INCAYTUNov 13, 2025
AYTU BIOPHARMA, INC. (AYTU) has filed its Q3 2025 quarterly report (Form 10-Q), providing investors with an update on the company's financial performance and operational status.
Company Filing
MAJOR8-KAYTU BIOPHARMA, INCAYTUNov 13, 2025
AYTU BIOPHARMA, INC (AYTU) announced the resignation of its Chief Executive Officer, effective immediately. This unexpected leadership change comes at a critical juncture for the company and may impact its strategic direction and ability to execute on key growth initiatives.
Company Filing
ROUTINESCHEDULE 13G/AAYTU BIOPHARMA, INCAYTUNov 12, 2025
Ownership stake disclosure by Philotimo Fund, LP (amended)
Company Filing
Philotimo Fund, LP, filed by

Older filings on EDGAR

Get an email when AYTU BIOPHARMA, INC files

Filings

8 insider filings

AYTU BIOPHARMA, INC. (AYTU) has filed its Q3 2025 quarterly report (Form 10-Q), providing investors with an update on the company's financial performance and operational status.

AYTU BIOPHARMA, INC (AYTU) announced the resignation of its Chief Executive Officer, effective immediately. This unexpected leadership change comes at a critical juncture for the company and may impact its strategic direction and ability to execute on key growth initiatives.